UNSPSC 51161527: Ablukast

This classification denotes an anti-asthmatic agent with the molecular formula C28H34O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 000TKM5BBQ, chemically known as 2h-1-benzopyran-2-carboxylic acid, 6-acetyl-7-((5-(4-acetyl-3-hydroxy-2-propylphenoxy)pentyl)oxy)-3,4-dihydro-, (+-)- but generally known as ablukast, which bears US NIH Compound Identifier 57109. Ablukast most often appears in sodium form.

UNSPSC 51161527 Ablukast is a Commodity code identifying a specific pharmaceutical product — a leukotriene receptor antagonist used in asthma and allergy management — that state and local governments procure through their Medicaid programs, health departments, and institutional pharmacy networks. The scope of work under this code encompasses the supply and distribution of the branded or generic drug formulation to eligible patients within state and local health systems, correctional facilities, and public insurance programs. Issuing bodies are predominantly state Medicaid agencies and state health departments, with some activity from county health systems and municipal public-health clinics that operate formulary procurement or contract-pharmacy services.

The source provides no recent state and local contract opportunities tagged to this code. Without posted solicitations, RFPs, RFQs, or ITBs in the recent-opportunities block, the geographic spread and current procurement activity cannot be characterized. State and local Medicaid programs do procure pharmaceutical products regularly, and ablukast remains on many state formularies, but this particular code shows no detectable recent solicitation activity in the source.